Genmab

Also known as Genmab, Inc

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab (Suzhou) Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US.

Key facts

Company.name: Genmab A/S
Company.logo: Genmab.svg
Company.logo_size: 250px
Company.type: Public
Company.traded_as: (ADR)OMX Copenhagen 25 component
Company.founder: Florian Schönharting and Lisa Drakeman
Company.location: Copenhagen, Denmark
Company.num_locations: 4 (2023)
Company.industry: Biotechnology
Company.products: DARZALEX/DARZALEX FASPRO EPKINLY/TEPKINLY Kesimpta RYBREVANT TALVEY TECVAYLI TEPEZZA Tivdak
Company.revenue: DKK 16.474 billion (2023)
Company.operating_income: DKK 5.321 billion (2023)
Company.net_income: DKK 4.352 billion (2023)
Company.num_employees: 2,204 (2023)

via Wikipedia infobox

Research organization · ROR

Type: Company
Founded: 1999
Location: Copenhagen, Denmark
Status: Active

Website →Wikipedia →ROR →

GRID grid.476284.b · ISNI 0000 0004 0647 0126

Official website

Home | Genmab

Genmab is an international biotech company specializing in antibody therapeutics for the treatment of cancer and other serious diseases

genmab.com →

Link to the official site · 7,768 chars · not written by Vinony

Wikidata facts

Official name: Genmab A/S
Employees: 1800
Revenue: 14595000000
Official website: www.genmab.com
Image: Genmab gebouw op Utrecht Science Park.jpg

Show 2 more facts

inception: 1998-06-11
social media followers: 1492

Sources (5)

via Wikidata · CC0

~8 min read

Article

13 sections

Contents

Technology
History
Executive history
Partnerships
Products
Pipeline
Proprietary Products
Approved Medicines/Products
Pipeline, Including Further Development for Approved Medicines
Programs Incorporating Genmab’s Innovation and Technology
Approved Medicines/Products
Pipeline, Partner-owned products incorporating Genmab’s innovation, ≥Phase 2 Development
References

[Skip to Main](javascript:void(0);)

![Genmab Logo](http://www.genmab.com/sfsites/c/cms/delivery/media/MCDSE2PWSVPNBPLCVHGSAXBZXZOA?channelId=0apMb00000000kn)